Monday, June 6, 2011     17:19

 

 

Fantastic Bioimaging (FAB) is a sino-foreign joint venture of medical imaging contract research organization (CRO), and is the first imaging CRO in China. FAB is a division of Tigermed. It provides medical imaging service for clinical trials by utilizing medical imaging as part of evaluation endpoints for efficacy for the pharmaceutical, biotech and medical device industries. With the technology, knowledge and experience of world-class professionals, and using local resources and the existing platform of Tigermed, FAB successfully developed and expanded a new way of thinking and operation of third-party independent image analysis in clinical trials, connected with world levels, and promoted the development of Chinese medical imaging CRO.

中外合资的医学影像合同研究组织(CRO) - 杭州英放生物科技有限公司(Fantastic Bioimaging)是泰格医药旗下的子公司。
作为国内首家第三方独立医学影像CRO,英放为药品、医疗器械临床试验疗效终点评估,提供专业的医学影像服务。借助国际一流专业人才的技术、知识和经验,利用本土资源和泰格医药现有的平台,英放成功开拓和拓展了一个临床试验第三方独立影像分析的新的思维和运作方式,与世界水平接轨,促进中国医学影像CRO的发展。

Copyright © 2013 Fantastic Bioimaging